This webpage is intended for UK healthcare professionals. If you are not a healthcare professional, please click here.

The UK’s
#1
choice

Metoject® is the UK’s most prescribed methotrexate autoinjector, offering
the flexibility of 10 dosing options and a ≤5 second injection time1,2

Now with
0
buttons

Now with the simplicity of a new, button-free PEN, purpose designed with patient-friendly features

The UK’s
#1
choice

Now with
0
buttons

Metoject® is the UK’s most prescribed
methotrexate autoinjector, offering
the flexibility of 10 dosing options
and a ≤5 second injection time1,2

Now with the simplicity
of a new, button-free PEN,
purpose designed with
patient-friendly features

New features designed to improve the patient experience:*

  • Button-free autoinjector PEN
  • Acoustic signal at beginning and end of injection
  • Inspection window to see when injection complete
  • Hidden needle inside blue needle cover
  • Larger labelling with colour code
  • Angular shape with anti-rolling-feature

*New compared to the previous Metoject® PEN device.

Metoject® PEN Prescribing Information

Patient self-injection guide

Metoject® PEN is a single use device and is injected ONCE a week. Please read the following instructions carefully.

Remove the cap.
Do not bend or twist

Position the PEN

Start the injection

Hold the PEN in place to complete the injection

Finishing the injection

Disposing of the PEN

Patient self-injection guide video

Metoject® PEN is a single use device and is injected ONCE a week. Please read the following instructions carefully.

Keep up to date with everything Metoject®!

To get the latest product and service updates about Metoject®, please fill out the form below and subscribe to our mailing list.

* indicates required

Please select all the ways you would like to hear from us:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. You will receive emails from marketingteam@medacpharma.co.uk

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

References:

  1. Data on file
  2. Metoject PEN SPC: Available at, https://www.medicines.org.uk/emc/search?q=metoject. Last accessed Sept 2023

Further Information & Questions

Visit our contact page to submit an enquiry

REPORTING SIDE EFFECTS

Adverse events should be reported using the forms and information found at yellowcard.mhra.gov.uk

Please also report any adverse events by email to medac drug safety at drugsafety@medac.de

Contact Us

For more information, please contact medac Pharma:

Tel: +44 (0)1786 458086
Email: info@medacpharma.co.uk
Web: medacpharma.co.uk

medac Pharma LLP
Scion House
Stirling University Innovation Park
Stirling
FK9 4NF

Terms & Conditions
Privacy Policy
Cookies Policy
medac Pharma website
Copyright © medac Pharma LLP 2024

medacuk084/09/2023
September 2023